Teacher Retirement System of Texas grew its holdings in shares of Pediatrix Medical Group, Inc. (NYSE:MD - Free Report) by 92.3% in the first quarter, according to its most recent filing with the SEC. The firm owned 371,756 shares of the company's stock after acquiring an additional 178,386 shares during the quarter. Teacher Retirement System of Texas owned about 0.43% of Pediatrix Medical Group worth $5,387,000 as of its most recent SEC filing.
A number of other institutional investors also recently added to or reduced their stakes in the business. Nomura Asset Management Co. Ltd. lifted its holdings in shares of Pediatrix Medical Group by 95.3% in the fourth quarter. Nomura Asset Management Co. Ltd. now owns 2,500 shares of the company's stock valued at $33,000 after buying an additional 1,220 shares during the period. GAMMA Investing LLC raised its position in shares of Pediatrix Medical Group by 219.5% during the first quarter. GAMMA Investing LLC now owns 2,569 shares of the company's stock worth $37,000 after purchasing an additional 1,765 shares during the period. AlphaQuest LLC raised its position in shares of Pediatrix Medical Group by 65.9% during the fourth quarter. AlphaQuest LLC now owns 5,066 shares of the company's stock worth $66,000 after purchasing an additional 2,012 shares during the period. Smartleaf Asset Management LLC raised its position in shares of Pediatrix Medical Group by 750.9% during the fourth quarter. Smartleaf Asset Management LLC now owns 6,901 shares of the company's stock worth $91,000 after purchasing an additional 6,090 shares during the period. Finally, Tower Research Capital LLC TRC raised its position in shares of Pediatrix Medical Group by 218.0% during the fourth quarter. Tower Research Capital LLC TRC now owns 7,445 shares of the company's stock worth $98,000 after purchasing an additional 5,104 shares during the period. Institutional investors and hedge funds own 97.71% of the company's stock.
Pediatrix Medical Group Stock Down 0.4%
Shares of NYSE:MD traded down $0.06 during trading on Thursday, hitting $13.50. 620,882 shares of the company were exchanged, compared to its average volume of 744,270. The stock has a market cap of $1.16 billion, a price-to-earnings ratio of -13.37, a P/E/G ratio of 0.91 and a beta of 1.25. The firm has a fifty day moving average price of $13.94 and a two-hundred day moving average price of $13.89. Pediatrix Medical Group, Inc. has a fifty-two week low of $6.81 and a fifty-two week high of $17.67. The company has a current ratio of 1.81, a quick ratio of 1.81 and a debt-to-equity ratio of 0.75.
Pediatrix Medical Group (NYSE:MD - Get Free Report) last announced its earnings results on Tuesday, May 6th. The company reported $0.33 EPS for the quarter, topping the consensus estimate of $0.25 by $0.08. Pediatrix Medical Group had a negative net margin of 4.17% and a positive return on equity of 17.43%. The company had revenue of $458.36 million for the quarter, compared to analysts' expectations of $451.44 million. During the same period last year, the firm earned $0.20 earnings per share. The business's revenue for the quarter was down 7.4% on a year-over-year basis. As a group, research analysts anticipate that Pediatrix Medical Group, Inc. will post 1.38 earnings per share for the current fiscal year.
Wall Street Analyst Weigh In
A number of equities research analysts have recently issued reports on MD shares. UBS Group cut their target price on Pediatrix Medical Group from $18.50 to $16.00 and set a "neutral" rating on the stock in a research report on Monday, May 12th. Macquarie increased their price objective on Pediatrix Medical Group from $19.00 to $20.00 and gave the company an "outperform" rating in a report on Thursday, May 8th. Finally, Truist Financial decreased their target price on Pediatrix Medical Group from $18.00 to $16.00 and set a "hold" rating for the company in a research note on Friday, April 11th. Four research analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. According to MarketBeat, the company presently has a consensus rating of "Hold" and an average target price of $16.67.
Get Our Latest Stock Report on MD
About Pediatrix Medical Group
(
Free Report)
Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.
See Also

Before you consider Pediatrix Medical Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Pediatrix Medical Group wasn't on the list.
While Pediatrix Medical Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.